https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-publishes-data-on-pancreasure-in-hereditary-and-familial-high-risk-individuals 2026-10-05 https://investors.immunovia.com/en/press-releases/artikel?slug=notice-of-extraordinary-general-meeting-in-immunovia-ab-publ-2 2026-09-28 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-carries-out-a-rights-issue-of-units-of-approximately-sek-63-million 2026-09-28 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-submits-formal-request-for-medicare-coverage-of-pancreasure 2026-09-28 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-presents-survey-data-showing-strong-patient-support-for-blood-based-tests-to-detect-pancreatic-cancer-at-an-earlier-stage 2026-08-13 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-publishes-interim-report-for-april-june-2026 2026-08-06 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-invites-to-a-presentation-on-the-q2-report-2026 2026-08-03 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-announces-new-performance-data-for-pancreasure-ahead-of-upcoming-application-for-medicare-coverage 2026-06-15 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-publishes-final-affirm-study-results-in-journal-of-clinical-oncology-confirming-strong-diagnostic-performance-of-pancreasure 2026-06-10 https://investors.immunovia.com/en/press-releases/artikel?slug=bulletin-from-the-annual-general-meeting-on-13-may-2026-in-immunovia-ab-publ 2026-05-13 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-publishes-interim-report-for-january-march-2026-1 2026-05-07 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-publishes-interim-report-for-january-march-2026 2026-05-07 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-launches-assure-registry-to-evaluate-real-world-clinical-impact-of-pancreasure-in-high-risk-pancreatic-cancer-surveillance 2026-05-05 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-invites-to-a-presentation-on-the-q1-report-and-2026-objectives 2026-05-04 https://investors.immunovia.com/en/press-releases/artikel?slug=notice-of-annual-general-meeting-in-immunovia-ab-publ-1 2026-04-13 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-publishes-the-annual-report-for-2025 2026-04-10 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-publishes-full-year-report-for-2025 2026-02-24 https://investors.immunovia.com/en/press-releases/artikel?slug=invitation-to-presentation-of-immunovias-q4-2025-report 2026-02-23 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-attends-aktiespararna-life-science 2026-01-23 https://investors.immunovia.com/en/press-releases/artikel?slug=the-board-of-directors-of-immunovia-withdraws-proposal-for-reverse-share-split-and-cancels-extraordinary-general-meeting 2026-01-20 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-receives-state-regulatory-approval-for-pancreasure-in-california-and-initiates-commercial-rollout 2026-01-19 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-establish-the-2026-nomination-committee 2026-01-15 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovias-analytical-validation-study-of-pancreasure-published-in-diagnostics 2025-12-22 https://investors.immunovia.com/en/press-releases/artikel?slug=notice-of-extraordinary-general-meeting-in-immunovia-ab-publ-1 2025-12-17 https://investors.immunovia.com/en/press-releases/artikel?slug=the-board-of-directors-of-immunovia-proposes-a-reverse-share-split 2025-12-17 https://investors.immunovia.com/en/press-releases/artikel?slug=change-in-number-of-shares-and-votes-in-immunovia-ab-publ-1 2025-11-28 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-receives-final-medicare-payment-rate-for-pancreasure-test 2025-11-26 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-publishes-interim-report-for-july-september-2025 2025-11-26 https://investors.immunovia.com/en/press-releases/artikel?slug=verifi-study-published-in-peer-reviewed-journal-current-oncology 2025-11-24 https://investors.immunovia.com/en/press-releases/artikel?slug=invitation-to-immunovias-q3-presentation 2025-11-20 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-carries-out-a-directed-issue-of-shares-to-guarantors-in-connection-with-the-completed-rights-issue 2025-10-29 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovias-pancreasure-study-published-in-leading-journal-gastroenterology 2025-10-27 https://investors.immunovia.com/en/press-releases/artikel?slug=pancreasure-clinical-validation-data-to-be-presented-at-the-american-gastroenterology-annual-scientific-meeting 2025-10-27 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-announces-outcome-of-the-rights-issue 2025-10-23 https://investors.immunovia.com/en/press-releases/artikel?slug=the-last-day-of-trading-in-subscription-rights-in-immunovias-rights-issue 2025-10-16 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovias-laboratory-receives-cap-accreditation 2025-10-13 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-highlights-pancreasure-presentation-at-inherited-gastrointestinal-cancers-meeting 2025-10-10 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-publishes-information-document-regarding-rights-issue 2025-10-03 https://investors.immunovia.com/en/press-releases/artikel?slug=bulletin-from-the-extraordinary-general-meeting-in-immunovia-ab-publ 2025-09-29 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-announces-final-terms-of-rights-issue 2025-09-25 https://investors.immunovia.com/en/press-releases/artikel?slug=pancreasure-demonstrates-88-sensitivity-and-98-specificity-in-interim-analysis-of-third-validation-study 2025-09-24 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-secures-control-of-pancreasure-supply-chain-and-achieves-cost-reduction-through-licensing-agreement 2025-09-22 https://investors.immunovia.com/en/press-releases/artikel?slug=inova-schar-cancer-adopts-immunovias-pancreasure-test-for-its-high-risk-surveillance-program 2025-09-15 https://investors.immunovia.com/en/press-releases/artikel?slug=centers-for-medicare-and-medicaid-services-issues-preliminary-payment-determination-for-immunovias-pancreasure-test 2025-09-11 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-enters-into-top-guarantee-commitments-for-the-upcoming-rights-issue 2025-09-08 https://investors.immunovia.com/en/press-releases/artikel?slug=pancreasure-test-for-early-detection-of-pancreatic-cancer-available-to-high-risk-patients-first-tests-already-ordered 2025-09-02 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-publishes-interim-report-for-january-june-2024 2025-08-28 https://investors.immunovia.com/en/press-releases/artikel?slug=notice-of-extraordinary-general-meeting-in-immunovia-ab-publ 2025-08-27 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-carries-out-a-rights-issue-of-approximately-sek-100-million-and-secures-bridge-loans 2025-08-27 https://investors.immunovia.com/en/press-releases/artikel?slug=invitation-to-immunovias-q2-presentation 2025-08-25 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-set-to-launch-pancreasure-in-the-us-on-september-2nd-shares-commercial-strategy 2025-08-19 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovias-analytical-validation-study-recognized-for-its-scientific-excellence-by-the-adlm 2025-07-28 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-appoints-natalie-carfora-as-vp-market-access-and-reimbursement 2025-07-21 https://investors.immunovia.com/en/press-releases/artikel?slug=pancreasure-test-receives-ama-cpt-code-for-billing-and-reimbursement 2025-07-01 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovias-model-development-study-published-in-cancers 2025-06-09 https://investors.immunovia.com/en/press-releases/artikel?slug=leiden-university-to-study-immunovias-pancreasure-test-in-group-at-unusually-high-risk-for-pancreatic-cancer 2025-06-04 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-selected-for-presentation-at-edrn-scientific-workshop-in-us-on-may-21 2025-05-21 https://investors.immunovia.com/en/press-releases/artikel?slug=bulletin-from-the-annual-general-meeting-on-14-may-2025-in-immunovia-ab-publ 2025-05-14 https://investors.immunovia.com/en/press-releases/artikel?slug=invitation-to-immunovias-q1-presentation 2025-05-14 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-publishes-interim-report-for-january-march-2025 2025-05-14 https://investors.immunovia.com/en/press-releases/artikel?slug=clariti-study-featured-in-best-of-digestive-disease-week 2025-05-07 https://investors.immunovia.com/en/press-releases/artikel?slug=pancreasure-immunovias-next-generation-test-for-early-detection-of-pancreatic-cancer 2025-05-05 https://investors.immunovia.com/en/press-releases/artikel?slug=change-in-number-of-shares-and-votes-in-immunovia-ab-publ 2025-04-30 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-ab-announces-outcome-of-exercise-of-warrants-series-to-3 2025-04-17 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-to-present-at-aktiespararnas-life-science-event-on-april-23 2025-04-17 https://investors.immunovia.com/en/press-releases/artikel?slug=notice-of-annual-general-meeting-in-immunovia-ab-publ 2025-04-14 https://investors.immunovia.com/en/press-releases/artikel?slug=last-day-of-trading-in-warrants-series-to-3-in-immunovia 2025-04-11 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovias-ceo-and-board-members-announce-intention-to-fully-exercise-their-to-3-warrants 2025-04-10 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-publishes-the-annual-report-for-2024-5f8e27be 2025-04-02 https://investors.immunovia.com/en/press-releases/artikel?slug=the-exercise-period-for-warrants-series-to-3-begins-today-7fa6a97e 2025-04-01 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-announces-determined-exercise-price-for-warrants-series-to-3-4d76b260 2025-03-27 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-provides-further-positive-data-from-the-verifi-study-of-its-next-generation-pancreatic-cancer-test-a2fe13a1 2025-03-24 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-to-host-a-webcast-to-share-more-data-from-the-successful-verifi-clinical-validation-study-3f31a814 2025-03-21 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-announces-another-successful-clinical-validation-of-its-next-generation-pancreatic-cancer-test-4ff642c7 2025-03-19 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovias-clariti-study-results-selected-for-prestigious-presentation-at-the-worlds-largest-gastroenterology-conference-813d9363 2025-03-03 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-publishes-full-year-report-for-2024-5ca9fd98 2025-02-25 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-initiates-search-for-a-new-cfo-to-support-commercialization-in-the-usa-bca69eeb 2025-02-21 https://investors.immunovia.com/en/press-releases/artikel?slug=invitation-to-immunovias-q4-presentation-fb7273ab 2025-02-21 https://investors.immunovia.com/en/press-releases/artikel?slug=change-in-number-of-shares-and-votes-in-immunovia-ab-publ-fb0caf18 2025-01-31 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-ab-announces-outcome-of-exercise-of-warrants-series-to-2-40ea99a8 2025-01-20 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-ab-publ-presents-nomination-committee-7519b62b 2025-01-08 https://investors.immunovia.com/en/press-releases/artikel?slug=the-exercise-period-for-warrants-of-series-to-2-beings-today-b44b6063 2025-01-02 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-announces-determined-exercise-price-for-warrants-series-to-2-and-conditionally-securing-65-of-the-warrant-programme-dca23ab7 2024-12-27 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-discovery-study-published-in-top-protein-research-journal-0b81c971 2024-12-20 https://investors.immunovia.com/en/press-releases/artikel?slug=end-of-the-year-2024-letter-from-immunovia-ceo-jeff-borcherding-d0151eed 2024-12-19 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-ceo-and-board-members-announce-intention-to-fully-exercise-their-to2-warrants-73427283 2024-12-18 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-to-host-a-webcast-with-the-opportunity-to-learn-more-about-the-positive-clinical-validation-of-its-next-generation-pancreatic-cancer-test-b4538529 2024-12-16 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-announces-financial-calendar-for-financial-year-2025-2026-fc305d34 2024-12-11 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-announces-positive-outcome-and-strong-accuracy-in-the-clinical-validation-of-its-next-generation-test-for-pancreatic-cancer-70a4ea49 2024-12-09 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-to-present-at-the-redeye-technology-and-life-science-day-4b478367 2024-11-28 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-publishes-interim-report-for-january-september-2024-02165bca 2024-11-27 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-presents-model-development-study-results-at-meeting-of-the-collaborative-group-of-the-americas-inherited-gastrointestinal-cancers-fec559d4 2024-11-15 https://investors.immunovia.com/en/press-releases/artikel?slug=invitation-to-immunovias-q3-presentation-6e9aabbe 2024-11-12 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-presents-data-from-model-development-study-at-meeting-of-the-precede-pancreatic-cancer-research-consortium-a4619a6e 2024-11-07 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-has-successfully-acquired-all-blood-samples-required-to-clinically-validate-its-next-generation-test-for-pancreatic-cancer-9adf33f9 2024-10-07 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-completes-analytical-validation-of-its-next-generation-pancreatic-cancer-test-af446bdf 2024-10-02 https://investors.immunovia.com/en/press-releases/artikel?slug=change-in-number-of-shares-and-votes-in-immunovia-ab-publ-fd973346 2024-09-30 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-presents-data-from-model-development-study-at-2024-aacr-advances-in-pancreatic-cancer-medical-conference-5197912f 2024-09-16 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-carries-out-a-directed-issue-of-units-to-guarantors-in-connection-with-the-completed-rights-issue-d9a6289f 2024-09-12 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-announces-final-outcome-in-rights-issue-827e5e66 2024-09-03 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-publishes-preliminary-outcome-in-rights-issue-8bcf3acb 2024-09-02 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-publishes-prospectus-in-connection-with-forthcoming-rights-issue-79bdb7c9 2024-08-12 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-announces-final-terms-of-rights-issue-b8d3f2d0 2024-08-06 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-publishes-interim-report-for-january-june-2024-2696efd7 2024-08-05 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovias-next-generation-test-to-be-included-in-large-study-of-pancreatic-cysts-funded-by-the-u-s-national-institutes-of-health-cb075405 2024-08-05 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-files-us-patent-application-to-protect-its-next-generation-test-08f8ae68 2024-08-02 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-completes-development-of-its-pancreatic-cancer-detection-test-after-substantially-increasing-test-accuracy-c8cc1bbe 2024-08-01 https://investors.immunovia.com/en/press-releases/artikel?slug=invitation-to-immunovias-q2-presentation-6a260f15 2024-07-29 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-presents-data-from-discovery-study-at-2024-pancreasfest-medical-conference-fb8b51a7 2024-07-25 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovias-new-lab-staffed-and-operational-after-rapid-implementation-1b2fed40 2024-07-02 https://investors.immunovia.com/en/press-releases/artikel?slug=bulletin-from-the-annual-general-meeting-on-19-june-2024-in-immunovia-ab-publ-51c5126d 2024-06-19 https://investors.immunovia.com/en/press-releases/artikel?slug=notice-of-annual-general-meeting-in-immunovia-ab-publ-72473286 2024-05-20 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-carries-out-a-rights-issue-of-units-of-approximately-sek-70-million-and-raises-bridge-loans-de5ec1e7 2024-05-20 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-streamlines-lab-operations-with-move-to-research-triangle-park-north-carolina-4849f69f 2024-04-29 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-appoints-dr-lisa-ford-as-clinical-laboratory-director-71d1ab17 2024-04-29 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-publishes-the-annual-report-for-2023-14175ba7 2024-04-29 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-publishes-interim-report-for-january-march-2024-380350f7 2024-04-29 https://investors.immunovia.com/en/press-releases/artikel?slug=invitation-to-immunovias-q1-presentation-c17d0d75 2024-04-23 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-announces-updated-financial-calendar-417637fa 2024-04-22 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-announces-positive-results-from-the-model-development-study-for-its-next-generation-pancreatic-cancer-detection-test-20f7a497 2024-04-22 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-successfully-develops-assays-to-measure-targeted-proteins-for-its-next-generation-pancreatic-cancer-test-moving-forward-towards-model-development-study-6513bdca 2024-04-09 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-announces-updated-financial-calendar-8898cfa2 2024-03-12 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-publishes-full-year-report-for-2023-c6d6f33b 2024-02-21 https://investors.immunovia.com/en/press-releases/artikel?slug=invitation-to-immunovias-q4-presentation-9d853b31 2024-02-14 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-appoints-norma-alonzo-palma-as-new-vice-president-of-clinical-and-medical-affairs-775e2aae 2024-01-31 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-announces-financial-calendar-for-financial-year-2024-0e3fd67d 2024-01-04 https://investors.immunovia.com/en/press-releases/artikel?slug=bulletin-from-the-extraordinary-general-meeting-in-immunovia-ab-d5c326b6 2023-11-21 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-publishes-interim-report-for-january-september-2023-7a122655 2023-11-09 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-successfully-completes-discovery-phase-of-next-generation-test-development-6240ac7f 2023-11-07 https://investors.immunovia.com/en/press-releases/artikel?slug=invitation-to-immunovias-q3-presentation-f6e8861a 2023-11-02 https://investors.immunovia.com/en/press-releases/artikel?slug=convening-notice-extraordinary-general-meeting-in-immunovia-ab-publ-3435c092 2023-10-27 https://investors.immunovia.com/en/press-releases/artikel?slug=nomination-committee-appointed-for-immunovia-ab-publ-75fb9f28 2023-10-03 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-publishes-interim-report-for-january-june-2023-af0f74b3 2023-08-30 https://investors.immunovia.com/en/press-releases/artikel?slug=invitation-to-immunovias-q2-presentation-11a86b22 2023-08-23 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-announces-updated-financial-calendar-33577421 2023-07-19 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-to-significantly-restructure-to-focus-resources-on-its-next-generation-blood-test-for-pancreatic-cancer-detection-d9442105 2023-07-11 https://investors.immunovia.com/en/press-releases/artikel?slug=chief-executive-officer-jeff-borcherding-buys-immunovia-shares-dcac0206 2023-06-09 https://investors.immunovia.com/en/press-releases/artikel?slug=change-in-number-of-shares-and-votes-in-immunovia-ab-publ-30985138 2023-05-31 https://investors.immunovia.com/en/press-releases/artikel?slug=bulletin-from-the-annual-general-meeting-in-immunovia-ab-d2bb81de 2023-05-26 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-publishes-interim-report-for-january-march-2023-86753583 2023-05-23 https://investors.immunovia.com/en/press-releases/artikel?slug=changes-to-the-nomination-committees-proposal-to-the-annual-general-meeting-2023-in-immunovia-ab-publ-76285283 2023-05-22 https://investors.immunovia.com/en/press-releases/artikel?slug=invitation-to-immunovias-q1-presentation-1f83fed9 2023-05-17 https://investors.immunovia.com/en/press-releases/artikel?slug=the-board-member-philipp-von-hugo-resigns-from-immunovias-board-at-his-own-request-12980c78 2023-05-06 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-ab-appoints-new-ceo-84f2b3af 2023-04-29 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-to-discuss-adoption-of-immraytm-pancan-d-with-key-opinion-leaders-on-may-3-2023-8d9f54be 2023-04-26 https://investors.immunovia.com/en/press-releases/artikel?slug=convening-notice-annual-general-meeting-in-immunovia-ab-publ-71702b54 2023-04-25 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-publishes-the-annual-report-for-2022-d9ce35e1 2023-04-21 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-to-participate-in-national-pancreas-foundation-webinar-on-biomarkers-and-liquid-biopsy-for-early-detection-of-pancreatic-cancer-08b36fb3 2023-04-20 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-announces-outcome-of-the-rights-issue-836f7748 2023-04-12 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-publishes-prospectus-relating-to-the-rights-issue-e379aa16 2023-03-17 https://investors.immunovia.com/en/press-releases/artikel?slug=bulletin-from-the-extraordinary-general-meeting-in-immunovia-ab-02bc8f9b 2023-03-16 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-appoints-karl-stone-as-new-chief-operating-officer-to-develop-randd-and-operations-9704b277 2023-03-01 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-publishes-full-year-report-for-2022-1c708146 2023-02-23 https://investors.immunovia.com/en/press-releases/artikel?slug=invitation-to-immunovias-q4-presentation-fad16768 2023-02-20 https://investors.immunovia.com/en/press-releases/artikel?slug=convening-notice-extraordinary-general-meeting-in-immunovia-ab-publ-b1936cc0 2023-02-20 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-resolves-on-a-rights-issue-of-approximately-sek-202-2-million-and-postpones-the-publication-of-the-quarterly-report-for-the-first-quarter-and-the-annual-general-meeting-7331f3c4 2023-02-20 https://investors.immunovia.com/en/press-releases/artikel?slug=consultation-process-with-swedish-unions-completed-0394c27a 2023-02-08 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-announces-updated-financial-calendar-for-financial-year-2023-6cbbb659 2023-01-19 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-realigning-swedish-operations-with-strategic-priorities-and-its-focus-on-the-us-commercialization-of-the-immray-pancan-d-test-d5dabf81 2023-01-19 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-appoints-lara-e-sucheston-campbell-as-head-of-clinical-and-medical-affairs-to-accelerate-commercial-strategy-of-immray-pancan-d-test-in-the-us-market-0bbb8498 2023-01-17 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-strengthens-us-organization-to-continue-commercialization-of-its-novel-immray-pancan-d-test-913d8a79 2022-12-05 https://investors.immunovia.com/en/press-releases/artikel?slug=centers-for-medicare-and-medicaid-services-finalizes-its-payment-determination-and-sets-a-rate-of-897-for-immunovias-immray-pancan-d-test-24f82ad5 2022-11-30 https://investors.immunovia.com/en/press-releases/artikel?slug=chief-executive-offier-philipp-mathieu-buys-immunovia-warrants-a49c9873 2022-11-16 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-announces-the-financial-calendar-for-financial-year-2023-ffd9e6da 2022-11-11 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-publishes-interim-report-jan-sep-2022-0d933c1c 2022-11-10 https://investors.immunovia.com/en/press-releases/artikel?slug=invitation-to-immunovias-q3-presentation-e067c969 2022-11-03 https://investors.immunovia.com/en/press-releases/artikel?slug=nomination-committee-appointed-for-the-2023-annual-general-meeting-of-immunovia-ab-publ-0d1111cc 2022-10-20 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-announces-executive-management-team-changes-to-accelerate-execution-of-strategic-priorities-0b138d3f 2022-10-19 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-launches-a-strategic-partnership-with-proteomedix-to-leverage-randd-efforts-with-increased-focus-on-commercialization-73053f48 2022-10-17 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-announces-positive-update-on-physician-experience-program-with-immray-pancan-d-58ab7c2f 2022-10-12 https://investors.immunovia.com/en/press-releases/artikel?slug=centers-for-medicare-and-medicaid-services-issues-preliminary-payment-rate-determination-for-immunovias-immray-pancan-d-test-2e027ffd 2022-09-26 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-publishes-interim-report-jan-june-2022-3cff738a 2022-08-24 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-to-present-at-gilmartin-groups-emerging-growth-company-showcase-a9746b2f 2022-08-23 https://investors.immunovia.com/en/press-releases/artikel?slug=invitation-to-immunovias-q2-presentation-a03386ac 2022-08-22 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-inc-issued-clinical-and-public-health-laboratory-license-from-california-dept-of-public-health-for-immray-pancan-d-test-dcf7925c 2022-08-11 https://investors.immunovia.com/en/press-releases/artikel?slug=cpt-pla-code-for-the-immray-pancan-d-test-approved-e25b8d06 2022-07-05 https://investors.immunovia.com/en/press-releases/artikel?slug=the-pandia-1-study-for-early-detection-of-pancreatic-cancer-in-newly-onset-type-2-diabetics-moves-into-next-phase-6ade4731 2022-06-30 https://investors.immunovia.com/en/press-releases/artikel?slug=invitation-to-immunovias-presentation-of-panfam-1-results-50ab0de9 2022-06-27 https://investors.immunovia.com/en/press-releases/artikel?slug=panfam-1-results-partly-inconclusive-4c36bce9 2022-06-27 https://investors.immunovia.com/en/press-releases/artikel?slug=philipp-mathieu-appointed-ceo-of-immunovia-ab-a3adc491 2022-06-02 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-inc-market-access-increases-when-achieving-clinical-laboratory-permits-from-pennsylvania-and-maryland-departments-of-health-making-immray-pancan-d-test-available-in-48-us-states-4b799bb9 2022-05-23 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-inc-achieves-clinical-laboratory-licensure-from-rhode-island-dept-of-health-making-immray-pancan-d-test-available-in-46-us-states-cc83242c 2022-05-17 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-strengthens-its-us-team-through-the-appointment-of-natalie-carfora-as-head-of-market-access-us-8b0199cd 2022-05-16 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-publishes-interim-report-january-march-2022-8ff8b606 2022-04-28 https://investors.immunovia.com/en/press-releases/artikel?slug=invitation-to-immunovias-q1-presentation-c16beaed 2022-04-21 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-cpt-pla-code-submission-for-the-immray-pancan-d-test-is-on-the-agenda-of-american-medical-association-48e2678e 2022-04-14 https://investors.immunovia.com/en/press-releases/artikel?slug=communique-from-the-annual-general-meeting-in-immunovia-ab-c44bcdd5 2022-04-07 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-appoints-jeff-borcherding-previously-chief-marketing-officer-at-myriad-genetics-to-lead-immunovias-us-business-e91efc99 2022-03-28 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-publishes-the-annual-report-for-2021-20e2f05f 2022-03-10 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-inc-laboratory-receives-accreditation-from-college-of-american-pathologists-a-major-step-in-the-nationwide-us-roll-out-of-immray-pancan-d-07111bc7 2022-03-08 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-further-strengthens-ip-portfolio-for-its-immray-pancan-d-signature-6d690205 2022-03-07 https://investors.immunovia.com/en/press-releases/artikel?slug=notice-to-the-annual-general-meeting-of-immunovia-ab-publ-aa515b0f 2022-03-04 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-invited-to-the-42nd-annual-cowen-health-care-conference-cc6c5519 2022-02-22 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-publishes-full-year-report-2021-e090042d 2022-02-17 https://investors.immunovia.com/en/press-releases/artikel?slug=immray-pancan-d-peer-reviewed-blinded-validation-study-now-published-in-clinical-and-translational-gastroenterology-f89103d5 2022-02-17 https://investors.immunovia.com/en/press-releases/artikel?slug=invitation-to-immunovias-q4-presentation-cbb152fb 2022-02-04 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-postpones-annual-general-meeting-pending-the-temporary-meetings-act-bd200a57 2022-02-03 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-appoints-philipp-mathieu-as-acting-ceo-b7e94d2e 2022-01-20 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovias-ceo-to-step-down-during-2022-b0153507 2021-11-30 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-appoints-new-senior-director-investor-relations-and-corporate-communications-f9b77f73 2021-11-26 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-honored-world-pancreatic-cancer-day-by-a-grand-opening-celebration-of-the-us-subsidiary-immunovia-inc-864fbfd2 2021-11-23 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-publishes-report-for-the-third-quarter-2021-ac01bb84 2021-11-11 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-to-present-at-jefferies-london-healthcare-conference-1aca17b7 2021-11-05 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-inc-s-medical-director-dr-thomas-king-invited-as-keynote-speaker-by-us-national-cancer-institute-0435bb62 2021-10-29 https://investors.immunovia.com/en/press-releases/artikel?slug=invitation-to-presentation-of-immunovias-interim-report-january-september-2021-ce3dda8c 2021-10-29 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-receives-presidential-poster-award-at-the-american-college-of-gastroenterology-annual-scientific-meeting-be09f64d 2021-10-28 https://investors.immunovia.com/en/press-releases/artikel?slug=nomination-committee-appointed-for-the-2022-annual-general-meeting-of-immunovia-ab-publ-e9752199 2021-10-25 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-appoints-new-chief-financial-officer-799613af 2021-10-15 https://investors.immunovia.com/en/press-releases/artikel?slug=the-us-based-pancreatic-cancer-action-network-informs-their-members-about-immunovias-blood-test-immray-pancan-d-c3f11885 2021-09-14 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-enters-licensing-agreement-with-jw-bioscience-for-pancreatic-cancer-biomarkers-99d135b1 2021-09-13 https://investors.immunovia.com/en/press-releases/artikel?slug=board-member-of-immunovia-purchases-shares-in-the-company-c7eab0d8 2021-09-03 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-publishes-report-for-the-second-quarter-2021-11c6e109 2021-08-19 https://investors.immunovia.com/en/press-releases/artikel?slug=invitation-to-presentation-of-immunovias-interim-report-january-june-2021-ac7c7df3 2021-08-11 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-provides-updates-on-the-price-for-the-immray-tm-pancan-d-test-in-the-us-and-improved-test-performance-in-the-familial-hereditary-risk-group-8d67665d 2021-08-10 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-inc-receives-approval-to-begin-testing-patients-for-pancreatic-cancer-with-the-immray-pancan-d-test-58617154 2021-08-04 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-inc-receives-certificate-of-registration-clinical-laboratory-licensure-still-pending-ff416853 2021-06-30 https://investors.immunovia.com/en/press-releases/artikel?slug=ceo-patrik-dahlen-purchases-immunovia-shares-3134280d 2021-05-28 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-to-host-a-key-opinion-leader-event-on-the-clinical-use-of-immray-pancan-d-33124791 2021-05-27 https://investors.immunovia.com/en/press-releases/artikel?slug=member-of-immunovias-board-of-directors-purchases-shares-in-the-company-d66289e6 2021-05-12 https://investors.immunovia.com/en/press-releases/artikel?slug=annual-general-meeting-immunovia-ab-4e4b1db4 2021-05-06 https://investors.immunovia.com/en/press-releases/artikel?slug=members-of-immunovias-board-of-directors-purchase-shares-in-the-company-a648da94 2021-05-04 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-reports-interim-report-january-march-2021-092b7413 2021-04-28 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-reiterates-its-road-to-reimbursement-for-the-immray-pancan-d-test-46613b34 2021-04-22 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-presents-update-on-us-market-size-for-immray-pancan-d-in-the-familial-hereditary-risk-group-04400ed2 2021-04-21 https://investors.immunovia.com/en/press-releases/artikel?slug=invitation-to-presentation-of-immunovias-interim-report-january-march-2021-c6457ed5 2021-04-21 https://investors.immunovia.com/en/press-releases/artikel?slug=immray-pancan-d-highlighted-in-meeting-arranged-by-pancreatic-cancer-action-network-ad1958c1 2021-04-16 https://investors.immunovia.com/en/press-releases/artikel?slug=kallelse-till-arsstamma-i-immunovia-ab-b500d665 2021-03-31 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-reports-positive-results-of-the-blinded-clinical-validation-of-immray-tm-pancan-d-blood-test-in-usa-275de590 2021-03-29 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-reports-improved-test-performance-of-immray-tm-pancan-d-in-detecting-early-stage-pancreatic-cancer-in-high-risk-symptomatic-patients-b40d2e74 2021-03-29 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-publishes-the-annual-report-for-the-financial-year-2020-a960d75c 2021-03-12 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-publishes-data-sets-on-the-optimization-study-and-commercial-test-model-study-e6968fd1 2021-02-26 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-full-year-report-2020-418dea46 2021-02-17 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovias-panfam-1-prospective-study-gathers-over-3000-familial-hereditary-pancreatic-cancer-risk-samples-and-will-be-analysed-in-the-second-half-of-2021-c283627f 2021-02-15 https://investors.immunovia.com/en/press-releases/artikel?slug=invitation-to-presentation-of-immunovias-full-year-report-2020-on-february-17-2021-c7981a23 2021-02-11 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-on-track-for-immray-pancan-d-sales-start-in-q1-2021-b396085c 2021-02-10 https://investors.immunovia.com/en/press-releases/artikel?slug=chief-executive-officer-patrik-dahlen-buys-immunovia-warrants-068fc5a0 2021-01-19 https://investors.immunovia.com/en/press-releases/artikel?slug=proteomic-data-derived-from-immunovias-immray-platform-allows-differential-diagnosis-of-difficult-to-distinguish-autoimmune-diseases-3d510664 2021-01-07 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-publishes-link-to-webinar-no-3-on-immray-pancan-d-verification-study-and-clinical-use-bcd5e2a9 2020-12-14 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-to-host-a-third-webinar-in-the-series-on-immray-pancan-d-verification-study-and-clinical-use-d10376f8 2020-12-11 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-announces-investor-relations-changes-930b8fb5 2020-12-07 https://investors.immunovia.com/en/press-releases/artikel?slug=members-of-immunovias-board-of-directors-purchase-shares-in-the-company-97651a56 2020-12-03 https://investors.immunovia.com/en/press-releases/artikel?slug=invitation-to-telephone-conference-in-response-to-dagens-industris-article-published-on-december-1-39697108 2020-12-02 https://investors.immunovia.com/en/press-releases/artikel?slug=chief-executive-officer-patrik-dahlen-buys-immunovia-shares-9297cda9 2020-11-17 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-reports-third-quarter-interim-report-january-september-2020-4b56937f 2020-11-12 https://investors.immunovia.com/en/press-releases/artikel?slug=corrected-version-nomination-committee-appointed-for-the-2021-annual-general-meeting-of-immunovia-ab-publ-b82fff74 2020-11-11 https://investors.immunovia.com/en/press-releases/artikel?slug=nomination-committee-appointed-for-the-2021-annual-general-meeting-of-immunovia-ab-publ-99305440 2020-11-10 https://investors.immunovia.com/en/press-releases/artikel?slug=invitation-to-presentation-of-immunovia-s-interim-report-january-september-2020-on-november-12-2020-f708406f 2020-11-06 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-provides-complementary-details-on-the-immray-pancan-d-verification-study-a4ec1c91 2020-11-02 https://investors.immunovia.com/en/press-releases/artikel?slug=change-in-the-number-of-shares-and-votes-in-immunovia-ab-publ-644f4e3a 2020-10-30 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-to-host-webinar-introducing-new-ceo-patrik-dahlen-5e8f8dff 2020-10-28 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-provides-complementary-information-on-the-immray-pancan-d-verification-and-validation-studies-a029899a 2020-10-27 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-announces-completion-of-analysis-from-the-immray-pancan-d-verification-study-a87caf13 2020-10-26 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-announces-positive-results-from-the-immray-pancan-d-verification-study-1271ff9b 2020-09-29 https://investors.immunovia.com/en/press-releases/artikel?slug=summary-from-the-extraordinary-general-meeting-of-immunovia-700d31f6 2020-09-23 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-announces-management-team-changes-3a2dd2c6 2020-09-02 https://investors.immunovia.com/en/press-releases/artikel?slug=notice-of-extraordinary-general-meeting-in-immunovia-ab-c6906bc4 2020-08-31 https://investors.immunovia.com/en/press-releases/artikel?slug=registration-details-for-immunovias-second-webinar-in-the-series-on-immray-pancan-d-commercial-test-model-study-and-update-on-launch-activities-bc0d3cf4 2020-08-28 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-announces-ceo-transition-appoints-patrik-dahlen-as-new-ceo-728fed4a 2020-08-26 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-reports-second-quarter-interim-report-january-june-2020-4f2bb034 2020-08-20 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-to-host-a-second-webinar-in-the-series-on-immray-pancan-d-commercial-test-model-study-and-update-on-launch-activities-b2d2b0bf 2020-08-18 https://investors.immunovia.com/en/press-releases/artikel?slug=invitation-to-presentation-of-immunovia-s-interim-report-january-june-2020-on-august-20-2020-7f5f9783 2020-08-13 https://investors.immunovia.com/en/press-releases/artikel?slug=change-in-the-number-of-shares-and-votes-in-immunovia-ab-publ-02f8303e 2020-06-30 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-targeting-long-term-market-penetration-of-30-for-immray-pancan-d-3a1a02f8 2020-06-30 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-to-present-a-satellite-symposium-at-the-european-pancreatic-club-epc-international-association-of-pancreatologys-iap-annual-meeting-july-2-2020-4c0a4317 2020-06-29 https://investors.immunovia.com/en/press-releases/artikel?slug=registration-details-for-immunovias-virtual-investor-day-on-tuesday-june-30-2020-8eb950d3 2020-06-26 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-expands-its-lung-cancer-program-based-on-encouraging-results-from-the-current-discovery-study-061aa94e 2020-06-26 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-to-host-virtual-investor-day-on-tuesday-june-30-2020-3e9801af 2020-06-15 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-raised-400m-sek-to-further-accelerate-the-market-introduction-of-the-first-test-for-early-detection-of-pancreatic-cancer-the-immray-pancan-d-1518d3a9 2020-06-09 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-has-completed-a-directed-share-issue-and-thereby-raises-approximately-msek-400-cac21e6f 2020-06-04 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-intends-to-carry-out-a-directed-share-issue-through-an-accelerated-book-building-process-cf75d590 2020-06-03 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-provides-forth-update-during-covid-19-pandemic-65b062db 2020-05-27 https://investors.immunovia.com/en/press-releases/artikel?slug=invitation-to-immunovias-update-4-on-covid-19-company-response-0f287bf8 2020-05-25 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-provides-third-update-during-covid-19-pandemic-9d6614e7 2020-05-13 https://investors.immunovia.com/en/press-releases/artikel?slug=invitation-to-immunovias-update-3-on-covid-19-company-response-0065a66f 2020-05-12 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-report-from-agm-336381ab 2020-05-08 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-reports-first-quarter-interim-report-january-march-2020-2e9f4080 2020-04-28 https://investors.immunovia.com/en/press-releases/artikel?slug=invitation-to-presentation-of-immunovia-s-interim-report-january-march-2020-on-april-28-2020-6882b846 2020-04-22 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-and-global-pharmaceutical-company-agree-on-early-termination-of-lung-cancer-collaboration-9f4320aa 2020-04-08 https://investors.immunovia.com/en/press-releases/artikel?slug=kallelse-till-arsstamma-i-immunovia-ab-1794f2aa 2020-04-03 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-takes-action-during-covid-19-pandemic-and-remains-focused-on-launch-of-immray-pancan-d-e438ee5c 2020-04-01 https://investors.immunovia.com/en/press-releases/artikel?slug=invitation-to-a-company-update-on-the-covid-19-response-70c241ae 2020-03-30 https://investors.immunovia.com/en/press-releases/artikel?slug=board-member-hans-johansson-buys-immunovia-shares-4afe664f 2020-03-26 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-publishes-the-annual-report-for-the-financial-year-2019-bd7ebd0a 2020-03-20 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-full-year-report-2019-6ca40c4a 2020-02-14 https://investors.immunovia.com/en/press-releases/artikel?slug=invitation-to-presentation-of-immunovia-s-full-year-report-2019-on-february-14-2020-6aab161c 2020-02-10 https://investors.immunovia.com/en/press-releases/artikel?slug=the-crown-princess-of-sweden-and-prince-daniel-visited-today-immunovia-in-lund-09cb84eb 2020-01-30 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-strengthen-management-with-new-senior-vp-of-sales-north-america-ahead-of-the-immray-pancan-d-test-launch-3f93abab 2020-01-13 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-announces-achieving-a-major-milestone-with-the-successful-completion-of-the-immray-tm-pancan-d-commercial-test-model-study-with-high-accuracy-3d30d9be 2019-12-19 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-strengthens-management-team-ahead-of-its-commercial-launch-of-immray-pancan-d-d990ceac 2019-12-05 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-continues-with-next-stage-of-the-lung-cancer-project-together-with-global-pharma-partner-aa3692ec 2019-11-29 https://investors.immunovia.com/en/press-releases/artikel?slug=correction-immunovia-interim-report-january-september-2019-eb69bf0c 2019-11-08 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-interim-report-january-september-2019-07fde996 2019-11-08 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-ab-publ-nomination-committee-appointed-for-agm-2020-86c513c9 2019-11-04 https://investors.immunovia.com/en/press-releases/artikel?slug=invitation-to-presentation-of-immunovia-s-interim-report-january-september-2019-on-november-8-2019-7480bbfa 2019-10-31 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-provides-an-update-on-its-rheumatoid-arthritis-pipeline-project-and-announces-new-collaboration-28c605f6 2019-10-22 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-provides-an-update-on-its-lung-cancer-pipeline-projects-e769b420 2019-10-02 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-announces-company-on-track-with-commercial-test-model-study-65f6e354 2019-09-30 https://investors.immunovia.com/en/press-releases/artikel?slug=increase-in-share-capital-and-number-of-shares-in-immunovia-5f981e70 2019-09-30 https://investors.immunovia.com/en/press-releases/artikel?slug=certain-persons-within-the-senior-management-have-sold-shares-to-enable-financing-of-shares-through-immunovias-share-option-program-08cbd730 2019-09-24 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-and-world-class-teaching-hospital-finalize-agreement-for-collection-of-pancreatic-cancer-blood-samples-for-immray-pancan-d-5503b8e0 2019-09-12 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-announces-the-agenda-for-todays-webinar-bb8ecffd 2019-09-09 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-to-host-webinar-series-on-immray-pancan-d-966c24c9 2019-09-03 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-interim-report-january-june-2019-43632e27 2019-08-23 https://investors.immunovia.com/en/press-releases/artikel?slug=invitation-to-presentation-of-immunovia-s-interim-report-april-june-2019-on-august-23-2019-372bd100 2019-08-19 https://investors.immunovia.com/en/press-releases/artikel?slug=erlangen-university-hospital-and-immunovia-enter-into-a-collaboration-agreement-for-the-collection-of-pancreatic-cancer-blood-samples-for-the-final-steps-of-immray-pancan-d-development-a8a92fc9 2019-07-17 https://investors.immunovia.com/en/press-releases/artikel?slug=results-on-the-immray-pancan-d-optimization-study-to-be-presented-at-pancreasfest-2019-dddd527f 2019-07-11 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovias-ceo-mats-grahn-sells-48-000-immunovia-shares-to-a-swedish-institutional-investor-3b9e15c0 2019-06-19 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-announces-excellent-results-across-all-symptomatic-risk-groups-from-immray-pancan-d-optimization-work-4048350e 2019-06-03 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovias-panfam-1-the-largest-study-of-hereditary-pancreatic-cancer-risk-gathers-momentum-in-the-us-90e1a6e3 2019-05-16 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-to-present-at-jefferies-2019-global-healthcare-conference-in-new-york-city-june-4-7-2019-8b2cd42b 2019-05-15 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-announces-optimization-work-is-progressing-on-schedule-and-according-to-plan-b30f997e 2019-04-29 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-report-from-agm-aaf87877 2019-04-26 https://investors.immunovia.com/en/press-releases/artikel?slug=correction-immunovia-interim-report-january-march-2019-c6bbdc13 2019-04-24 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-interim-report-january-march-2019-0a388abe 2019-04-24 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-advances-strategic-collaboration-with-primary-care-physicians-in-the-us-to-build-awareness-of-the-importance-of-early-detection-of-pancreatic-cancer-f2ee10af 2019-04-12 https://investors.immunovia.com/en/press-releases/artikel?slug=corrected-immunovia-and-university-college-of-london-sign-agreement-to-expand-validation-studies-of-immray-pancan-d-for-early-signs-and-symptoms-47994558 2019-04-10 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-and-university-college-of-london-sign-agreement-to-extendvalidation-studies-of-immray-pancan-d-for-early-signs-and-symptoms-ab17cb48 2019-04-08 https://investors.immunovia.com/en/press-releases/artikel?slug=kallelse-till-arsstamma-i-immunovia-ab-7ddf683b 2019-03-20 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-publishes-the-annual-report-for-the-financial-year-2018-e070b467 2019-03-04 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-provides-an-update-on-the-optimization-work-to-meet-the-expected-performance-for-commercialization-of-immray-pancan-d-ae48478f 2019-03-04 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-full-year-report-january-december-2018-d64e9e9e 2019-02-14 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-to-participate-in-upcoming-investor-conferences-in-march-d94336f9 2019-02-14 https://investors.immunovia.com/en/press-releases/artikel?slug=invitation-to-presentation-of-immunovia-s-full-year-report-2018-on-february-14-2019-b238901b 2019-02-12 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-ab-announces-appointment-of-senior-director-of-investor-relations-a32fe371 2019-02-12 https://investors.immunovia.com/en/press-releases/artikel?slug=new-european-sites-in-immunovias-panfam-1-the-largest-ever-prospective-multicenter-clinical-study-for-early-detection-of-pancreatic-cancer-27ac2b71 2019-02-11 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-invited-to-present-at-jefferies-2018-london-healthcare-conference-9dd8ecef 2018-11-13 https://investors.immunovia.com/en/press-releases/artikel?slug=mcgill-yale-and-universities-of-pennsylvania-and-massachusetts-join-panfam-1-the-largest-ever-prospective-multicenter-clinical-study-for-early-detection-of-pancreatic-cancer-f37c93e8 2018-11-13 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-interim-report-january-september-2018-add86d36 2018-11-07 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-sponsors-primary-care-educational-symposium-at-fenway-park-in-honor-of-world-pancreatic-cancer-day-7aba8ca3 2018-11-06 https://investors.immunovia.com/en/press-releases/artikel?slug=invitation-to-presentation-of-immunovia-s-interim-report-january-september-2018-on-november-7-2018-d995034d 2018-11-05 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-ab-publ-nomination-committee-appointed-for-agm-2019-6b0d9ba6 2018-10-26 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-announces-strategic-focus-centered-on-immray-blood-based-biomarker-signatures-for-rheumatoid-arthritis-within-autoimmunity-b639c1a2 2018-10-08 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-panfam-1-clinical-trial-now-available-on-clinicaltrials-gov-the-largest-clinical-trials-database-in-the-world-61f82033 2018-10-04 https://investors.immunovia.com/en/press-releases/artikel?slug=invitation-to-conference-call-regarding-immunovias-autoimmune-diseases-strategy-on-october-8-2018-55f23c72 2018-09-28 https://investors.immunovia.com/en/press-releases/artikel?slug=increase-in-share-capital-and-number-of-shares-in-immunovia-db1c211b 2018-09-28 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-interim-report-january-june-2018-0e3a233d 2018-08-24 https://investors.immunovia.com/en/press-releases/artikel?slug=invitation-to-presentation-of-immunovia-s-interim-report-january-june-2018-and-comments-to-the-previously-published-autoimmunity-study-results-3821415c 2018-08-23 https://investors.immunovia.com/en/press-releases/artikel?slug=breakthrough-in-autoimmune-testing-immraytm-based-novel-biomarker-signature-identifies-patients-with-anti-ccp-negative-rheumatoid-arthritis-59389bf2 2018-08-22 https://investors.immunovia.com/en/press-releases/artikel?slug=retrospective-study-results-for-immray-pancan-d-conclude-immunovia-needs-to-do-further-optimizations-to-meet-the-expected-performance-d992f669 2018-08-16 https://investors.immunovia.com/en/press-releases/artikel?slug=journal-of-clinical-oncology-publishes-that-immray-pancan-d-serum-biomarker-test-detects-early-pancreatic-cancer-with-96-accuracy-da9afa43 2018-08-15 https://investors.immunovia.com/en/press-releases/artikel?slug=invitation-to-immunovias-telephone-conference-on-thursday-the-9th-of-august-2018-at-15-00-cet-a729a7f9 2018-08-09 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-s-blood-based-immray-biomarker-array-provides-highly-accurate-diagnosis-of-non-small-cell-lung-cancer-in-a-new-collaborative-study-be9fd1b2 2018-08-09 https://investors.immunovia.com/en/press-releases/artikel?slug=karolinska-institutet-participates-in-immunovias-panfam-1-prospective-clinical-study-for-early-detection-of-pancreatic-cancer-using-blood-based-test-e74df837 2018-08-03 https://investors.immunovia.com/en/press-releases/artikel?slug=change-in-number-of-shares-and-votes-in-immunovia-ab-publ-9d31e50d 2018-06-29 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-has-completed-a-directed-share-issue-of-approximately-sek-324-million-981cb5a2 2018-06-08 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-announces-its-intent-to-carry-out-a-directed-share-issue-17c5b07e 2018-06-07 https://investors.immunovia.com/en/press-releases/artikel?slug=linkoping-university-hospital-second-swedish-site-in-largest-ever-prospective-multicenter-clinical-study-for-early-detection-of-pancreatic-cancer-1ba93464 2018-05-22 https://investors.immunovia.com/en/press-releases/artikel?slug=spanish-major-private-hospital-joins-worlds-largest-study-of-familiar-risk-for-pancreatic-cancer-31cdb791 2018-05-04 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-report-from-agm-d824ce9d 2018-05-03 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-interim-report-january-march-2018-30edc72c 2018-04-27 https://investors.immunovia.com/en/press-releases/artikel?slug=invitation-to-presentation-of-immunovia-s-interim-report-january-march-2018-on-april-27-2018-e8ea56a5 2018-04-25 https://investors.immunovia.com/en/press-releases/artikel?slug=invitation-to-presentation-of-immunovia-s-interim-report-january-march-2018-on-april-27-2018-bf0e9dbe 2018-04-25 https://investors.immunovia.com/en/press-releases/artikel?slug=nyu-school-of-medicine-joins-panfam-1-prospective-study-for-the-early-detection-of-pancreatic-cancer-in-familiar-risk-groups-bd34b2ac 2018-04-12 https://investors.immunovia.com/en/press-releases/artikel?slug=kallelse-till-arsstamma-i-immunovia-ab-96baacd3 2018-04-03 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-published-prospectus-in-connection-with-the-change-of-listing-venue-to-nasdaq-stockholm-c75927c0 2018-03-26 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-has-been-approved-for-listing-on-nasdaq-stockholm-5efe8baf 2018-03-26 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-launches-new-website-today-b2805096 2018-03-23 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-announces-financial-targets-09e901bf 2018-03-12 https://investors.immunovia.com/en/press-releases/artikel?slug=spanish-center-santiago-de-compostela-joins-the-largest-ever-prospective-study-into-familial-risk-of-developing-pancreatic-cancer-72525ab8 2018-02-16 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-full-year-report-january-december-2017-6927847a 2018-02-15 https://investors.immunovia.com/en/press-releases/artikel?slug=invitation-to-presentation-of-immunovia-s-full-year-report-2017-on-february-15-2018-fa6dcab9 2018-02-12 https://investors.immunovia.com/en/press-releases/artikel?slug=massachusetts-general-hospital-joins-panfam-1-prospective-study-for-the-early-detection-of-pancreatic-cancer-in-familiar-risk-groups-8d413340 2018-02-08 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-accelerates-pancreas-cancer-study-of-new-onset-diabetics-by-adding-denmarks-diabetes-center-for-strategic-research-dd2-f5ee824b 2018-01-11 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-expands-multicenter-clinical-study-for-early-detection-of-pancreatic-cancer-through-collaboration-with-the-renowned-university-of-pittsburgh-a833e853 2017-12-22 https://investors.immunovia.com/en/press-releases/artikel?slug=sahlgrenska-university-hospital-first-swedish-site-in-the-largest-ever-prospective-clinical-study-for-early-detection-of-pancreatic-cancer-ecac61df 2017-12-20 https://investors.immunovia.com/en/press-releases/artikel?slug=invitation-to-immunovias-telephone-conference-on-wednesday-the-20th-of-december-2017-at-15-00-cet-0e040ba2 2017-12-18 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-initiates-the-worlds-largest-study-of-new-onset-diabetic-patients-in-a-prospective-pancreas-cancer-study-supported-by-swelife-752c65f5 2017-12-18 https://investors.immunovia.com/en/press-releases/artikel?slug=the-swedish-royal-technology-mission-2017-and-his-majesty-king-carl-xvi-gustaf-of-sweden-visited-immunovia-yesterday-d111ef2f 2017-11-30 https://investors.immunovia.com/en/press-releases/artikel?slug=world-pancreatic-cancer-day-is-today-if-pancreatic-cancer-is-found-early-it-saves-lives-febd4105 2017-11-16 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-will-hold-a-q3-report-telephone-conference-on-monday-nov-13th-a55eef8a 2017-11-13 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-interim-report-january-september-2017-4d8a0404 2017-11-10 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-ab-publ-nomination-committee-appointed-for-agm-2018-cfed943d 2017-11-07 https://investors.immunovia.com/en/press-releases/artikel?slug=university-college-london-hospital-starts-the-collection-of-blood-samples-to-evaluate-immray-pancan-d-in-symptomatic-patients-07d4b743 2017-11-02 https://investors.immunovia.com/en/press-releases/artikel?slug=increase-in-share-capital-and-number-of-shares-in-immunovia-6903d692 2017-10-31 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-receives-sek4-9-million-grant-from-swelife-accelerator-innovation-program-a4ffb947 2017-10-30 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-signs-major-autoimmune-biomarker-discovery-collaboration-with-linkoping-university-d5abb539 2017-10-23 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-ab-on-track-regarding-application-for-listing-on-nasdaq-stockholms-main-market-839f27a0 2017-10-02 https://investors.immunovia.com/en/press-releases/artikel?slug=management-and-employees-of-immunovia-subscribe-for-new-shares-by-exercising-warrants-60168209 2017-09-26 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-announces-collaboration-with-lund-university-diabetes-centre-for-the-early-detection-of-pancreatic-cancer-in-diabetes-risk-group-935c3dcb 2017-09-07 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-interim-report-january-june-2017-cafe6b9b 2017-08-23 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-invites-to-a-conference-call-on-august-23-2017-ae520798 2017-08-18 https://investors.immunovia.com/en/press-releases/artikel?slug=leading-expert-on-pancreatic-cancer-professor-stephen-pereira-at-university-college-london-joins-immunovias-scientific-advisory-board-63fe0e8b 2017-07-17 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-together-with-oregon-health-and-science-university-awarded-one-of-the-pancreatic-cancer-action-network-2017-research-grants-3c6f63a2 2017-06-30 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-establishes-us-headquarters-including-clia-reference-laboratory-in-boston-71e0e578 2017-06-28 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovias-immray-presents-biomarkers-that-differentiates-rheumatoid-arthritis-from-other-autoimmune-diseases-with-89-accuracy-0e01935d 2017-06-21 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-ab-announces-timetable-for-listing-on-nasdaq-stockholms-main-market-c645658b 2017-06-16 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-s-biomarker-signature-for-the-diagnosis-of-pancreatic-cancer-now-patented-in-japan-b30a9366 2017-06-13 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-stammokommunike-69994171 2017-04-25 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-interim-report-january-march-2017-d1f7394c 2017-04-20 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-inbjuder-till-telefonkonferens-den-20-april-2017-195e1491 2017-04-19 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-ab-kallar-till-arsstamma-och-publicerar-arsredovisning-for-rakenskapsaret-2016-8a776b0a 2017-03-24 https://investors.immunovia.com/en/press-releases/artikel?slug=final-data-from-major-swedish-study-confirms-that-immray-biomarker-microarray-differentiates-sle-from-other-autoimmune-diseases-with-96-accuracy-92c63287 2017-03-07 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-tillkannager-genomford-blocktransaktion-i-bolagets-aktier-fea5867b 2017-02-22 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-financial-statement-2016-7dbcbd87 2017-02-15 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-inbjuder-till-telefonkonferens-den-15-februari-2017-af0ee129 2017-02-14 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-presenterar-vid-vator-securities-unicorn-summit-56fcc8cc 2017-02-13 https://investors.immunovia.com/en/press-releases/artikel?slug=university-of-michigan-pancreatic-cancer-center-new-partner-in-immunovias-global-panfam-1-prospective-validation-study-bc9aaff6 2017-01-16 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-bjuder-in-till-telefonkonferens-tisdag-17-1-kl-16-00-a9934ab0 2017-01-13 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-announces-first-data-exceeding-90-accuracy-in-distinguishing-systemic-lupus-erythematosus-sle-from-other-autoimmune-diseases-in-new-study-be89c9b7 2017-01-12 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-shareholder-newsletter-q4-2016-f93761a0 2016-12-22 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-announces-the-start-of-panfam-1-the-largest-ever-prospective-multi-center-clinical-study-for-early-detection-of-pancreatic-cancer-6c146163 2016-12-20 https://investors.immunovia.com/en/press-releases/artikel?slug=summary-from-the-extraordinary-general-meeting-of-immunovia-702bb265 2016-12-09 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-announces-collaboration-with-nci-regarding-early-detection-of-pancreatic-cancer-in-the-new-onset-diabetes-risk-group-e281a9ad 2016-12-09 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-announces-collaboration-with-the-renowned-ramon-y-cajal-institute-for-health-research-irycis-in-madrid-0104c3e3 2016-12-09 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-awarded-2016-stars-of-innovation-prize-dfcc4aa7 2016-11-18 https://investors.immunovia.com/en/press-releases/artikel?slug=kallelse-till-extra-bolagsstamma-i-immunovia-ab-publ-1d96cf64 2016-11-16 https://investors.immunovia.com/en/press-releases/artikel?slug=world-pancreatic-cancer-day-lund-sweden-november-17-2016-its-about-time-0fc1410b 2016-11-15 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-announces-completion-of-preferential-rights-issue-of-sek-28-7-million-adding-to-previously-sek-189-9-million-directed-issue-6a8f5dc6 2016-10-19 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-chosen-as-one-of-the-three-most-innovative-small-to-mid-companies-in-europe-2016-cfeaf750 2016-10-13 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-insiders-transfer-subscription-rights-free-of-charge-e07f0717 2016-10-07 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-publishes-prospectus-regarding-preferential-rights-issue-406ec248 2016-09-26 https://investors.immunovia.com/en/press-releases/artikel?slug=the-board-of-directors-of-immunovia-resolves-on-a-directed-and-preferential-right-issue-3731979c 2016-09-15 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-intends-to-launch-a-directed-and-preferential-right-issue-cfb7488d 2016-09-14 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-holdig-detailed-talks-about-participation-in-a-large-consortium-that-will-address-the-largest-risk-group-for-pancreatic-cancer-f12e67a7 2016-09-05 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-half-year-report-2016-733a6561 2016-08-24 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-invitation-to-a-teleconference-on-24-august-2016-06a30da6 2016-08-17 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-announces-intention-to-apply-for-listing-on-nasdaq-stockholms-main-market-069a0e69 2016-08-16 https://investors.immunovia.com/en/press-releases/artikel?slug=prof-diane-simeone-from-university-of-michigan-medical-center-becomes-latest-appointment-to-immunovia-scientific-advisory-board-6c92a6fc 2016-07-15 https://investors.immunovia.com/en/press-releases/artikel?slug=world-leading-cancer-diagnostics-expert-professor-aldo-scarpa-appointed-to-immunovias-scientific-advisory-board-3c5a6a58 2016-07-05 https://investors.immunovia.com/en/press-releases/artikel?slug=leading-us-gastrointestinal-cancer-expert-professor-margaret-tempero-appointed-to-immunovias-scientific-advisory-board-b720c0be 2016-06-23 https://investors.immunovia.com/en/press-releases/artikel?slug=stammokommunike-59fc87bc 2016-05-31 https://investors.immunovia.com/en/press-releases/artikel?slug=double-pancreatic-cancer-survival-by-2020-77ee5ca5 2016-05-30 https://investors.immunovia.com/en/press-releases/artikel?slug=96-of-early-stage-pancreatic-cancer-patients-detected-in-a-clinical-validation-study-with-a-north-american-sample-cohort-088fa89a 2016-05-30 https://investors.immunovia.com/en/press-releases/artikel?slug=inbjudan-till-immunovia-informationsmote-i-stockholm-den-1-juni-kl-17-30-med-vd-matsgrahn-och-styrelseordforande-carl-borrebaeck-e0d7c6ca 2016-05-18 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-joins-more-than-40-global-pancreatic-cancer-organizations-at-inagural-meeting-e52d0a15 2016-05-09 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-kallar-till-arsstamma-2016-76cb2178 2016-04-26 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-appoints-dr-marco-del-chiaro-from-karolinska-institute-to-scientific-advisory-board-14e17fd1 2016-04-08 https://investors.immunovia.com/en/press-releases/artikel?slug=note-about-immunovia-and-immray-technology-information-on-newswires-and-social-media-4d290cad 2016-04-01 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-partners-with-leading-healthcare-consultingservices-firm-812d71ad 2016-03-09 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-launches-swedish-website-5d2c98bc 2016-03-08 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-starts-collaboration-with-multinational-life-science-company-on-new-systemic-lupus-erythematosus-sle-diagnostics-test-fd24431f 2016-02-29 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-year-end-report-2015-30ac44b9 2016-02-24 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-and-lund-university-start-clinical-validation-studies-of-systemic-lupus-erythematosus-sle-biomarker-signatures-cfe46a69 2016-02-10 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-announces-collaboration-with-mount-sinai-health-system-to-validate-early-detection-blood-test-for-pancreatic-cancer-dfeb0ee9 2016-02-09 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-and-the-university-of-liverpool-enter-into-a-collaboration-in-a-prospective-clinical-study-d3d337f9 2016-01-19 https://investors.immunovia.com/en/press-releases/artikel?slug=white-paper-outlines-predicted-impact-of-new-biomarker-diagnostic-technology-on-pancreatic-cancer-survival-rates-cf8703e3 2015-12-18 https://investors.immunovia.com/en/press-releases/artikel?slug=immray-pancan-d-detects-98-of-pancreatic-cancers-in-retrospective-study-with-1400-blood-samples-d1f08e19 2015-12-03 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovias-stock-increased-60-percent-on-first-day-of-trading-on-nasdaq-first-north-with-a-turnover-of-sek-28-5-million-3551b361 2015-12-02 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-approved-for-trading-on-nasdaq-first-north-as-of-december-1st-2015-df22cfb6 2015-11-26 https://investors.immunovia.com/en/press-releases/artikel?slug=immunovia-ohsu-collaborating-on-early-detection-test-for-pancreatic-cancer-901f8381 2015-10-05